Target Price | AUD5.46 |
Price | AUD4.76 |
Potential |
14.64%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target Medibank Private 2026 .
The average Medibank Private target price is AUD5.46.
This is
14.64%
register free of charge
AUD5.99
25.74%
register free of charge
AUD4.65
2.39%
register free of charge
|
|
A rating was issued by 14 analysts: 5 Analysts recommend Medibank Private to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Medibank Private stock has an average upside potential 2026 of
14.64%
register free of charge
|
Jun '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion AUD | 8.16 | 9.19 |
4.61% | 12.71% | |
EBITDA Margin | 10.14% | 8.35% |
1.52% | 17.65% | |
Net Margin | 6.14% | 7.09% |
2.79% | 15.46% |
7 Analysts have issued a sales forecast Medibank Private 2026 . The average Medibank Private sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Medibank Private EBITDA forecast 2026. The average Medibank Private EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Medibank Private Analysts have issued a net profit forecast 2026. The average Medibank Private net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Jun '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share AUD | 0.18 | 0.24 |
0.00% | 33.33% | |
P/E | 20.45 | |
EV/Sales | 1.41 |
12 Analysts have issued a Medibank Private forecast for earnings per share. The average Medibank Private EPS is
This results in the following potential growth metrics and future valuations:
Medibank Private...
Analyst | Rating | Action | Date |
---|---|---|---|
JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Sep 01 2025 |
JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Jul 13 2025 |
MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
Analyst Rating | Date |
---|---|
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 08 2025 |
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Sep 01 2025 |
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 17 2025 |
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 16 2025 |
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Jul 14 2025 |
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Jul 13 2025 |
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Mar 18 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.